Suchergebnisse - "Shaik, Naveed"

PubPharm (54)

1

Physiologically Based Pharmacokinetic Modeling of the Drug-Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study

enthalten in: Journal of clinical pharmacology | 2024

von Callegari, E. | Tse, S. | Doran, A. | +2

2

Physiologically Based Pharmacokinetic Modeling of the Drug–Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study

enthalten in: The Journal of Clinical Pharmacology | 2024

von Callegari, E. | Tse, S. | Doran, A. | +2

3

Lenacapavir : A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent

enthalten in: Molecular pharmaceutics | 2023

von Subramanian, R. | Tang, J. | Zheng, J. | +17

4

PK/PD model-informed dose selection for oncology phase I expansion : Case study based on PF-06939999, a PRMT5 inhibitor

enthalten in: CPT: pharmacometrics & systems pharmacology | 2023

von Guo, C. | Liao, K. | Li, M. | +3

5

Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia : results from the randomized, phase 3 BRIGHT AML 1019 trial

enthalten in: Leukemia | 2023

von Sekeres, M. | Montesinos, P. | Novak, J. | +17

CommentIn: Leukemia. 2023 Dec;37(12):2520-2521. - PMID 37816956

6

Current State and Opportunities with Long-acting Injectables : Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group

enthalten in: Pharmaceutical research | 2023

von Bauer, A. | Berben, P. | Chakravarthi, S. | +18

7

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group

enthalten in: Pharmaceutical research | 2023

von Bauer, A. | Berben, P. | Chakravarthi, S. | +18

8

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group

enthalten in: Pharmaceutical research | 2023

von Bauer, A. | Berben, P. | Chakravarthi, S. | +18

9

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group

enthalten in: Pharmaceutical research | 2023

von Bauer, A. | Berben, P. | Chakravarthi, S. | +18

10

PK/PD model‐informed dose selection for oncology phase I expansion : Case study based on PF‐06939999, a PRMT5 inhibitor

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2023

von Guo, C. | Liao, K. | Li, M. | +3

1
2
3
4
5
6
Nächster »
[6]